<?xml version="1.0" encoding="UTF-8"?>
<p>The idea of treating the host response to pandemic influenza has a highly plausible scientific rationale, but for global public health it is overwhelmingly compelling: simply put, there is no available practical alternative that physicians might use to reduce pandemic mortality. Many of the drugs being considered are produced as inexpensive generics in developing countries, including India. These drugs are widely available and are used by physicians in the daily care of patients. In spite of this, influential influenza scientists and health officials (including those at WHO) have shown no interest in this idea. Several reasons have been invoked to explain their lack of interest, including herding behaviour and social bias
 <xref rid="ref26" ref-type="bibr">26</xref>. The idea of treating the host response means they risk losing power, influence, reputation and financial support
 <xref rid="ref18" ref-type="bibr">18</xref>.
</p>
